Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesSolifenacin for Overactive Bladder: Patient-Reported Outcomes from a Large Placebo-Controlled Trial
Postgraduate Medicine, 10/15/09
Toglia MR et al. – Flexibly dosed, once–daily solifenacin was associated with statistically significant and clinically meaningful improvements in urgency and other symptom–specific bother and HRQL compared with placebo.
Related Articles
Efficacy of simplified bladder training in patients with overactive bladder receiving a solifenacin flexible-dose regimen: results from a randomized study
BJU International, 10/13/09
Relevance Score: 82%
Objective differences between overactive bladder patients with and without urodynamically proven detrusor overactivity
International Urogynecology Journal, 11/17/09
Relevance Score: 80%
Response to fesoterodine in patients with an overactive bladder and urgency urinary incontinence is independent of the urodynamic finding of detrusor overactivity
BJU International, 11/11/09
Relevance Score: 80%
Bladder problems could be linked to mental health
Internet Source, 10/28/09
Relevance Score: 80%
Is ultrasound estimation of bladder weight a useful tool in the assessment of patients with lower urinary tract symptoms
International Urogynecology Journal, 10/07/09
Relevance Score: 80%
Today in Other Drugs...keeping you current
Receive free subspecialty "5-minute updates" via email
Clinical applications for topical 5-fluorouracil in the treatment of dermatological disorders
Journal of Dermatological Treatment , 12/04/09
Non-psoriatic dermatologic uses of monoclonal antibody therapy
Journal of Dermatological Treatment , 12/04/09
Does Simvastatin Cause More Myotoxicity Compared with Other Statins
Annals of Pharmacotherapy, 12/03/09
Sponsor
Article Search
Sponsor